You searched for: cancer
1 to 8 of 8 results
Show
results per page
Matched phrases in profile:
The LACE study is a clinical trial comparing two types of surgery for women with early-stage cancer… Cancer specialists are aware that not only the survival time but also the quality of life is a key… The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: A retrospective study… feMMe: Uterus-preserving treatment of endometrial cancer… Prophylactic surgery and breast cancer… levonorgestrel intrauterrine device (LNG-IUD) to treat endometrial cancer. The next two steps… Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC… Background: Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the…
Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and …
Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national …
Matched phrases in profile:
Therapeutic Opportunity in Cancers with Poor Survival… Complex neoantigen prediction in cancers… genome sequencing technologies in biomedical research. In particular large cancer research…
Research officer, Medical Genomics
QIMR Berghofer Medical Research Institute
My research addressed the challenges related to key genomic components in tumour-immune editing variation in cancers with poor survival and predicting the responses to cancer immunotherapies. Characterizing genomic determinants in underlying response and resistance to cancer immunotherapy. Through w …
Matched phrases in profile:
Using published datasets, and tissue donated by Brisbane breast cancer patients, we're trying to… Post-transcriptional regulation of the breast cancer susceptibility gene BRCA1 by Hu Antigen-R… Development of new theranostic agents for metastatic breast cancer surveillance and treatment… Molecular validation of autofluorescence and narrow band imaging of oral cancer resection margins… Most of the time, treatments for early breast cancer successfully prevent metastatic spread, but… Biomarkers of triple-negative breast cancer progression and response to therapy… cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research… BRCA1 is a breast cancer susceptibility gene that is down-regulated in the majority of cases of…
Dr Jodi Saunus is a senior fellow who specialises in translational research on metastatic breast cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research in 2022 to help facilitate patient-focused research at the interface of biomedical R&D and clinical pra …
Matched phrases in profile:
modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank… Cancer genetics… Barbour. Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the… set of 89 esophageal cancer samples. The most hypermethylated tumors showed worse patient survival.…
Dr Sandra Brosda is a Research Fellow within the Surgical Oncology group led by Professor Andrew Barbour.
Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the University of Queensland in November 2020. Her research focused on biomarker discovery and intra-tumour heterogeneity …
Matched phrases in profile:
Cell biology: Ran, mitosis and the cancer Lconnection… Cancer chemotherapy… studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease… -9 phosphorylation in the regulation of apoptosis during development and in pathological states, including cancer.…
Paul Clarke is Director of the Frazer Institute, a leading translational medical research centre studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease. Professor Clarke became Director in 2017 and was previously Associate Dean (Research) in Medicine at the Un …
Matched phrases in profile:
immunological defenses and cancer immunosurveillance. Current research: My current research focuses… The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy… Reversing tumour necrosis factor-mediated immunosuppression to boost immunity against experimental CD19+ blood cancers… Background: Despite advances in treatment and earlier detection, cancer is… NK cells are highly efficient at preventing cancer metastasis but are infrequently found in the…
In 2012, I achieved a significant milestone by becoming the first student to complete a doctoral degree from the prestigious International PhD Program at Institute Pasteur, Paris/France. This accomplishment not only set the trajectory of my academic pursuits but also underscored my dedication and pa …
Matched phrases in profile:
SCG10-like protein (SCLIP) is a STAT3-interacting protein involved in maintaining epithelial morphology in MCF-7 breast cancer cells… movement of cancer cells from one site to another, involves remodeling of the cytoskeleton including…
Dr Dominic Ng graduated with a BSc (Hons) and gained his PhD from the University of Western Australia. His doctoral studies, conducted in the laboratory of Assoc. Prof. Marie Bogoyevitch, were focused on cardiomyocyte signalling mechanisms regulating pathological tissue growth (ie cardiac hypertroph …
Matched phrases in profile:
Local doxorubicin delivery via 3D‐printed porous scaffolds reduces systemic cytotoxicity and breast cancer recurrence in mice… projects on cancer and bone tissue engineering. Dr Shafiee has developed innovative tissue engineered… The concept of using macroscale porous scaffolds as local drug reservoirs to prevent cancer…
Dr Abbas Shafiee is a tissue engineering & regenerative medicine scientist interested in translational cell-based and tissue engineering strategies to treat human diseases.
Dr Shafiee completed his PhD in Professor Kiarash Khosrotehrani’s laboratory on stem cell biology. His research career durin …
My research program has been devoted to understanding human tissue development to develop advanced technologies for tissue regeneration.
1 to 8 of 8 results